BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Chemoprevention of Helicobacter pylori-associated Gastric Carcinogenesis in a Mouse Model; Is It Possible?

  • Hahm, Ki-Baik (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Song, Young-Joon (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Oh, Tae-Young (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Lee, Jeong-Sang (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Surh, Young-Joon (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Kim, Young-Bae (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Yoo, Byung-Moo (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Kim, Jin-Hong (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Ha, Sang-Uk (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Nahm, Ki-Taik (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Kim, Myung-Wook (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Kim, Dae-Yong (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine) ;
  • Cho, Sung-Won (Genomic Research Center for Gastroenterology, Ajou Helicobacter Research Group, Ajou University School of Medicine)
  • Published : 2003.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Although debates still exist whether Helicobacter pylori infection is really class I carcinogen or not, H. pylori has been known to provoke precancerous lesions like gastric adenoma and chronic atrophic gastritis with intestinal metaplasia as well as gastric cancer. Chronic persistent, uncontrolled gastric inflammations are possible basis for ensuing gastric carcinogenesis and H. pylori infection increased COX-2 expressions, which might be the one of the mechanisms leading to gastric cancer. To know the implication of long-term treatment of antiinflammatory drugs, rebamipide or nimesulide, on H. pylori-associated gastric carcinogenesis, we infected C57BL/6 mice with H. pylori, especially after MNU administration to promote carcinogenesis and the effects of the long-term administration of rebamipide or nimesulide were evaluated. C57BL/6 mice were sacrificed 50 weeks after H. pylori infection. Colonization rates of H. pylori, degree of gastric inflammation and other pathological changes including atrophic gastritis and metaplasia, serum levels and mRNA transcripts of various mouse cytokines and chemokines, and NF-${\kappa}B$ binding activities, and finally the presence of gastric adenocarcinoma were compared between H. pylori infected group (HP), and H. pylori infected group administered with long-term rebamipide containing pellet diets (HPR) or nimesulide mixed pellets (HPN). Gastric mucosal expressions of ICAM-1, HCAM, MMP, and transcriptional regulations of NF-${\kappa}B$ binding were all significantly decreased in HPR group than in HP group. Multi-probe RNase protection assay showed the significantly decreased mRNA levels of apoptosis related genes and various cytokines genes like IFN-$\gamma$, RANTES, TNF-$\alpha$, TNFR p75, IL-$1{\beta}$ in HPR group. In the experiment designed to provoke gastric cancer through MNU treatment with H. pylori infection, the incidence of gastric carcinoma was not changed between HP and HPR group, but significantly decreased in HPN group, suggesting the chemoprevention of H. pylori-associated gastric carcinogenesis by COX-2 inhibition. Long-term administration of antiinflammatory drugs should be considered in the treatment of H. pylori since they showed the molecular and biologic advantages with possible chemopreventive effect against H. pylori-associated gastric carcinogenesis. If the final concrete proof showing the causal relationship between H. pylori infection and gastric carcinogenesis could be obtained, that will shed new light on chemoprevention of gastric cancer, that is, that gastric/cancer could be prevented through either the eradication of H. pylori or lessening the inflammation provoked by H. pylori infection in high risk group.

Keywords

References

  1. Aihara, M., Imagawa, K, Funakoshi, Y, Ohmoto, Y. and Kikuchi, M. (1998) Effects of rebamipide on production of several cytokines by human peripheral blood mononuclear cells. Dig. Dis. Sci. 43, 160S-166S.
  2. Arakawa, T., Kobayashi, K, Yoshikawa, T. and Tamawski, A. (1998) Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig. Dis. Sci. 9, 5S-13S.
  3. Asaka, M., Takeda, H., Sugiyama, T. and Kato, M. (1997) What role does Helicobacter pylori play in gastric cancer? Gastroenterology 113, S56-S60. https://doi.org/10.1016/S0016-5085(97)80013-3
  4. Asaka, M., Kudo, M., Kato, M., Sugiyama, T. and Takeda, H. (1998) Long-term Helicobacter pylori infection from gastritis to gastric cancer. Aliment Pharmacol. Ther. 12, Suppl. 9-15. https://doi.org/10.1111/j.1365-2036.1998.00007.x
  5. Bamford, K B., Fan, x., Crowe, S. E., Leary, J. F., Gourley, W. K, Luthra, G. K, Brooks, E. G., Graham, D. Y, Reyes, V. E. and Ernst, P. B. (1998) Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell I phenotype. Gastroenterology 114, 482-492. https://doi.org/10.1016/S0016-5085(98)70531-1
  6. Baik, S. C., Youn, H. S., Chung, M. H., Lee, W. K, Cho, M. J., Ko, G. H., Kasai, H. and Rhee, K. H. (1996) Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res. 56, 1279-1282.
  7. Bechi, P., Balzi, M., Becciolini, A., Maugeri, A, Raggi, C. C., Amorosi, A. and Dei, R.. (1996) Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis. Am. J. Gastroenterol. 91, 271-276.
  8. Correa, P. (1995) Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol. 19, 37-43. https://doi.org/10.1097/00000478-199501000-00005
  9. Crabtree, J. E., Shallcross,. T. M., Heatley, R. V. and Wyatt, J. I. (1991) Mucosal tumor necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori-associated gastritis. Gut 32, 14730-1477.
  10. Davis, R. and Brogden, R. N. (1994) Nimeulide; An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drug 48, 431-454. https://doi.org/10.2165/00003495-199448030-00008
  11. Ernst, P. (1999) The role of inflammation in the pathogenesis of gasrtric cancer. Aliment Pharmacol. Ther. 13, 13-18. https://doi.org/10.1046/j.1365-2036.1999.00003.x
  12. Ernst, P. B., Crowe, S. E. and Reyes, V. E. (1997) How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 113, S35-S42. https://doi.org/10.1016/S0016-5085(97)80009-1
  13. Go, M. F. (1997) What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 113, 15-20. https://doi.org/10.1016/S0016-5085(97)70075-1
  14. Go, M. F. (2000) Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol. Ther. 16, 3-15.
  15. Hahm, K. B., Lee, K J., Choi, S. y, Kim, J. H., Cho, S. w., Yim, H., Park, S. J. and Chung, M. H. (1997) Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection. Am. J. Gastroenterol. 92, 1863-1857.
  16. Han, B. G., Kim, H. S., Rhee, K H., Han, H. S. and Chung, M. H. (1995) Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils. Pharmacol. Res. 32, 201-207. https://doi.org/10.1016/S1043-6618(05)80023-4
  17. Han, S. U., Kim, Y B., 100, H. J., Hahm, K B., Lee, W. H., Cho, Y K, Kim, D. Y and Kim, M. W. (2002) Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J. Gastroenterol. Hepatol. 17, 253-261. https://doi.org/10.1046/j.1440-1746.2002.02684.x
  18. Hnuma, S., Naito, Y, Yoshikawa, T., Takahashi, S., Takemura, T., Yoshida, N. and Kondo, M. (1998) In vitro studies indicating antioxidative properties of rebamipide. Dig. Dis. Sci. 43, 35S-39S.
  19. Israel, D. A. and Peek, R. M. (2001) Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol. Ther. 15, 1271-1290. https://doi.org/10.1046/j.1365-2036.2001.01052.x
  20. Jacoby, R.F., Seibert, K, Cole, C.E., Kelloff, G. and Lubet, R.A. (2000) The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatosis polyposis. Cancer Res. 40, 5040-5044.
  21. Jones, N. L., Day, A. S., Jennings, H. A. and Sherman, P. M. (1999) Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect. Immun. 67, 4237-4242.
  22. Keates, S., Hitti, Y S., Upton, M. and Kelly, C. P. (1997) Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology 113, 1099-1109. https://doi.org/10.1053/gast.1997.v113.pm9322504
  23. Kishimoto, S. (1992) Therapeutic effects of oral rebamipide and in combination with cimetidine on experimental gastritis in rats. Res. Commun. Chem. Pathol. Pharmacol. 78, 259-277.
  24. Konturek, P. C., Konturek, S. J., Pierzxhalski, P., Bielanski, W.. Duda. A ., Marlicz. K., Starzynska, T. and Hahn, E. G. (2001) Cancerogenesis in Helicobacter pylori infected stomach role of growth factors, apoptosis, and cyclooxygenases. Med. Sci. Monit. 7, 1092-1107.
  25. Lefebvre, O., Chenard, M. P., Masson, R., Linares, J., Dierich, A., LeMeur, M., Wendling, C., Tomasetto, C., Chambon, P. and Rio, M. C. (1996) Gastric mucosal abnormoalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274, 259-262. https://doi.org/10.1126/science.274.5285.259
  26. Mai, U. E., Perez-Perez, G. L., Allen J. B., Wahl, S. M., Blaser, M. J. and Smith, P. D. (1992) Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J. Exp. Med. 175, 517-525. https://doi.org/10.1084/jem.175.2.517
  27. Mckay, L. I. and Cidlowski, J. A. (1999) Molecular control of immune/inflammatory response; Interactions between nuclear factor-kB and steroid receptor-signaling pathway. Endocr. Rev. 20, 435-459. https://doi.org/10.1210/er.20.4.435
  28. Mohammadi, M., Czinn, S., Redline, R., Lycke, N. and Czinn, S. J. (1997) Murine CD4 T-cell response to Helicobacter infection: Thl cells enhance gastritis and Th2 cells reduce bacterial load. Gastroenterology 113, 1848-1857. https://doi.org/10.1016/S0016-5085(97)70004-0
  29. Momand, J. and Zambetti, G. P. (1997) MDM-2: "big brother" of p53. J. Cell. Biochem. 64, 343-352. https://doi.org/10.1002/(SICI)1097-4644(19970301)64:3<343::AID-JCB1>3.0.CO;2-V
  30. Mori, M., Honda, M., Shibuta, K., Baba, K., Nakashima, H ., Haraguchi, M., Koba, F., Ueo. H., Sugimachi, K. and Akiyoshi, T. (1996) Expression of ornithine decarboxylase mRNA in gastric carcinoma. Cancer 77, 1634-1638. https://doi.org/10.1002/(SICI)1097-0142(19960415)77:8+<1634::AID-CNCR8>3.3.CO;2-7
  31. Mori, N., Wada. A., Hirayama. T., Parks, T. P., Stratowa, C. and Yamamoto, N. (2000) Activation of intercellular adhesion molecule I expression by Helicobacter pylori is regulated by NF-kB in gastric epithelial cancer cells. Infect. Immun. 68, 1806-1814. https://doi.org/10.1128/IAI.68.4.1806-1814.2000
  32. Moss, S. F., Calam. J., Agarwal, B., Wang, S. and Holt, P. R. (1996) Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 38, 498-501. https://doi.org/10.1136/gut.38.4.498
  33. Moss, S. F. (1998) Cellular markers in the gastric precancerous process. Aliment Pharmacol. Ther. 12, 91-109. https://doi.org/10.1111/j.1365-2036.1998.00002.x
  34. Moss, S. F., Legon, S., Davies, J. and Calam, J. (1994) Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut 35, 1567-1570. https://doi.org/10.1136/gut.35.11.1567
  35. Peek, R. M., Miller, G. G., Tham, K. T., Perez-Perez, G. I., Zhao, X., Atherton, J. C. and Blaser, M. J. (1995) Heightened inflammatory response and cytokine expression in vivo to cag$A^{+}$ Helicobacter pylori strains. Lab. Invest. 73, 760-770.
  36. Peek, R. M., Moss, S. F., Tham, K. T., Perez-perez, G. J., Wang, S., Miller, G. G., Atherton, J. C., Holt, P. R. and Blaser, M. J. (1997) Helicobacter pylori cag$A^{+}$ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J. Natl. Cancer Inst. 89, 863-868. https://doi.org/10.1093/jnci/89.12.863
  37. RauteJin, H., Blomberg, B., Jamerot, G. and Danielsson, D. (1994) Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand. J. Gastroenterol. 29, 128-132. https://doi.org/10.3109/00365529409090450
  38. Reddy, B, Rao, C. V. and Seibert, K. (1996). Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56, 4566-4569.
  39. Rieder, G., Hatz, R. A., Moran, A. P., Walz, A., Stolte, M. and Enders, G. (1997) Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect. lmmun. 65, 3622-3630.
  40. Sakagarni, T., Dixon, M., ORourke, J., Howlett, R., Alderuccio, F., Vella, J., Shimoyama, T. and Lee, A. (1996) Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut 39, 639-648. https://doi.org/10.1136/gut.39.5.639
  41. Schreck, R., Albermann, K. and Baeuelre, P. A. (1992) Nuclear factor kappa B: an oxidative stress response transcription factor of eukaryotic cells. Free Radic. Res. Commun. 17.221-227. https://doi.org/10.3109/10715769209079515
  42. Sharma, S. A., Tummuru, M. K., Blaser, M. J. and Kerr, L. D. (1998) Activation of IL-8 gene expression by Helicobacter pylori is regulated by trabnscription factor nuclear factor-kappa B in gastric epithelial cells. J. Immunol. 160, 2401-2407.
  43. Steinbach, G., Lynch. P., Phillips, R., Wallace, M. H., Hawk, E., Gordon, G. B., Wakagayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L. and Levin, B. (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342, 1946-1952. https://doi.org/10.1056/NEJM200006293422603
  44. Sugiyama, A.. Maruta. F., Ikeno, T., Ishida, K.. Kawasaki, S., Katsuyama, T., Shimizu, N. and Tatematsu, M. (1998) Helicobacter pylori infection N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian Gerbils. Cancer Res. 58, 2067-2069.
  45. Sung, J. J., Keung, W. K., Go, M. Y. Y., To, K. F., Cheng, A. S. L., Ng. E. K. W. and Chan, F. K. (2000) Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am. J. Pathol. 157, 729-735. https://doi.org/10.1016/S0002-9440(10)64586-5
  46. Suzuki, M., Miura, S., Mori, M., Kai, A., Suzuki, H., Fukumura, D., Suematsu, M. and Tsuchiya, M. (1994) Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Gut 35, 1375-1378. https://doi.org/10.1136/gut.35.10.1375
  47. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N. and Schlemper, R. J (2001) Helicobacter pylori infection and the development of gastric cancer. N. Engl. J Med. 345, 784-789. https://doi.org/10.1056/NEJMoa001999
  48. Wang, J., Fan, X., Lindholm, c., Bennett, M., OConnoll, J., Shanahan, F., Brooks, E. G., Reyes, V. E. and Ernst, P. B. (2000) Helicobacter pylori modulates Iymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions. Infect. Immun. 68, 4303-4311. https://doi.org/10.1128/IAI.68.7.4303-4311.2000
  49. Yamaoka, Y., Kita, M., Kodama, T .. Sawai, N. and Imanishi, J. (1996) Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110. 1744-1752. https://doi.org/10.1053/gast.1996.v110.pm8964399
  50. Yamaoka, Y., Kodama, T., Kita, M., Imanishi, J., Kashima, K. and Graham, D. Y. (2001) Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter 6, 116- 124. https://doi.org/10.1046/j.1523-5378.2001.00017.x
  51. Yamasaki, K., Kanbe, T., Chijiwa, T.. Ishiyama, H. and Morita, S. (1987) Gastric mucosal protection by OPC-12579, a novel antiulcer compound, in the rats. Eur. J. Pharmacol. 142, 23-30. https://doi.org/10.1016/0014-2999(87)90649-2
  52. Yoshida, N., Granger, D. N., Evans, D. J., Evans, D. G., Graham, D. Y., Anderson, D. C, Wolf, R. E. and Kvietys, P. R. (1993) Mechanisms involved In Helicobacter pylori-induced inflammation. Gastroentemlogy 105, 1431-1440. https://doi.org/10.1016/0016-5085(93)90148-6
  53. Yoshida, N., Yoshikawa, T., Iinuma. S., Arai, M., Takenaka, S., Sakamoto, K., Miyajima, T., Nakamura, Y., Yagi, N., Naito, Y., Mukai, F. and Kondo, M. (1996) Rebamipide protects against activation of neutrophils by Helicobacter pylori. Dig. Dis. Sci. 41, 1139-1144. https://doi.org/10.1007/BF02088229
  54. Zhang, O. B., Nakashabendi, I.M., Mokhashi, M.S., Dawodu, J. B., Gemmell, C. G. and Russell, R. I. (1996) Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 38, 841-845. https://doi.org/10.1136/gut.38.6.841

Cited by

  1. The prevention of infection-associated cancers vol.32, pp.6, 2011, https://doi.org/10.1093/carcin/bgr054
  2. The expression level of TRAF1 in human gastric mucosa is related to virulence genotypes ofHelicobacter pylori vol.49, pp.8, 2014, https://doi.org/10.3109/00365521.2014.919015
  3. Mouse Models of Gastric Cancer vol.5, pp.1, 2013, https://doi.org/10.3390/cancers5010092
  4. Detouring the Undesired Route of Helicobacter pylori-Induced Gastric Carcinogenesis vol.3, pp.4, 2011, https://doi.org/10.3390/cancers3033018
  5. The Inflammatory Chemokine CCL5 and Cancer Progression vol.2014, 2014, https://doi.org/10.1155/2014/292376
  6. Special Licorice Extracts Containing Lowered Glycyrrhizin and Enhanced Licochalcone A PreventedHelicobacter pylori-Initiated, Salt Diet-Promoted Gastric Tumorigenesis vol.19, pp.3, 2014, https://doi.org/10.1111/hel.12121
  7. Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique vol.100, pp.9, 2005, https://doi.org/10.1111/j.1572-0241.2005.41688.x
  8. Flavones: An important scaffold for medicinal chemistry vol.84, 2014, https://doi.org/10.1016/j.ejmech.2014.07.013
  9. Chemoprevention of glandular stomach carcinogenesis through duodenogastric reflux in rats by a COX-2 inhibitor vol.123, pp.7, 2008, https://doi.org/10.1002/ijc.23742
  10. Gastric Carcinogenesis in the miR-222/221 Transgenic Mouse Model vol.49, pp.1, 2017, https://doi.org/10.4143/crt.2015.462
  11. How useful are the rodent animal models of gastric adenocarcinoma? vol.19, pp.8, 2004, https://doi.org/10.1111/j.1365-2036.2004.01911.x
  12. The Anti-inflammatory Effects of Acidic Polysaccharide from Artemisia capillaris on Helicobacter pylori Infection vol.18, pp.2, 2013, https://doi.org/10.15430/JCP.2013.18.2.161
  13. Developmental Phases of Inflammation-Induced Massive Lymphoid Hyperplasia and Extensive Changes in Epithelium in an Experimental Model of Allergy vol.12, pp.2, 2005, https://doi.org/10.1097/01.mjt.0000143699.91156.21
  14. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori vol.0, pp.0, 2006, https://doi.org/10.1111/j.1440-1746.2006.04194.x
  15. Chemopreventive effects of garlic and mugwort mixture extract on Helicobacter pylori-associated mouse gastric carcinogenesis vol.54, pp.3, 2014, https://doi.org/10.14405/kjvr.2014.54.3.171
  16. Helicobacter pylori infection and gastric cancer vol.42, pp.6, 2006, https://doi.org/10.1016/j.ejca.2006.01.020